• Exchange: London
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

BTG:LN

801.000 GBp 3.500 0.44%

As of 11:35:07 ET on 11/25/2014.

Snapshot for BTG PLC (BTG)

Open: 797.500 Day's Range: 795.000 - 805.000 Volume: 530,632
Previous Close: 797.500 52wk Range: 457.000 - 805.000 1-Yr Rtn: +53.45%

Stock Chart for BTG

No chart data available.
  • BTG:LN 801.000
  • 1D
  • 1M
  • 1Y
797.500
Interactive BTG Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for BTG

Current P/E Ratio (ttm) 72.8844
Estimated P/E(03/2015) 49.4444
Relative P/E vs. UKX 3.8851
Earnings Per Share (GBP) (ttm) 0.1099
Est. EPS (GBP) (03/2015) 0.1620
Est. PEG Ratio -
Market Cap (M GBP) 2,906.24
Shares Outstanding (M) 362.83
30 Day Average Volume 801,172
Price/Book (mrq) 5.0018
Price/Sale (ttm) 8.8036
Dividend Indicated Gross Yield -%
Cash Dividend (GBp) -
Dividend Ex-Date 06/07/2000
5 Year Dividend Growth -
Next Earnings Announcement 05/18/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for BTG

  • Revenue
  • Net Income (M/GBP)
  • Profit Margin (%)

Company Profile & Key Executives for BTG

BTG plc licenses, develops and commercializes pharmaceuticals and has a pipeline of development programs targeting neurological and other disorders, including varicose veins. The Company also has a substantial and growing revenue stream of milestone payments and royalties from out-licensed products.

Louise MakinCEO/Executive DirectorRolf SoderstromCFO/Executive Director
Peter StratfordCTO:Interventional MedicineGuenter R JanhoferChief Medical Officer/Head:Dev
More Company Profile & Key Executives for BTG

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil